Children and adolescents on Symdeko (tezacaftor/ivacaftor) and Orkambi (ivacaftor/lumacaftor) for cystic fibrosis (CF) had higher treatment adherence rates compared with…
Articles by Aisha I Abdullah PhD
Patients in the U.S. with cystic fibrosis (CF) and advanced lung disease are less likely to receive…
A review of 57 real-world studies found that people with cystic fibrosis (CF)…
A clinical study found that in youth with cystic fibrosis (CF) who are…
Krystal Biotech is expecting to start a Phase 1 clinical trial by early fall to test KB407Â for…
Treatment with MS1819 for exocrine pancreatic insufficiency (EPI) — when the pancreas does not release enough digestive enzymes and the…
Patient enrollment has been completed for a Phase 2 clinical trial testing the investigational therapy MS1819 in combination with …
Blood C-reactive protein (CRP) and calprotectin levels can reliably identify pulmonary exacerbations in cystic fibrosis (CF) patients,…
The U.S. Food and Drug Administration (FDA) has accepted for review an application to expand the use of…
People with cystic fibrosis (CF) and their families are largely satisfied with the…